期刊
CANCER LETTERS
卷 286, 期 2, 页码 145-153出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2009.04.027
关键词
Liver; Stem cell; Cancer stem cell; SP cell; Hepatocellular carcinoma
类别
资金
- Chiba Serum Institute Memorial Fund for Health Medical Welfare
- Ministry of Education, Culture, Sports, Science and Technology, Japan
- Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Corporation (JST)
Although the cancer stem cell (CSC) hypothesis was first proposed roughly 50 years ago, recent progress in stem cell biology and technologies has successfully achieved the identification of CSCs in a variety of cancers. CSCs are defined as a minor population which possesses a prominent ability to generate new tumors that faithfully reproduce the phenotype of original tumors in xenotransplant assays. Additionally, CSCs are able to self-renew and generate differentiated progenies to organize a hierarchical cell system in a similar fashion to normal stem cells. Although not all types of cancer follow the CSC theory, it provides an attractive cellular mechanism to account for the therapeutic resistance and recurrence of the disease. A minor population with CSC properties has been detected in a number of established hepatocellular carcinoma (HCC) cell lines and extensive analyses characterizing the CSC system in primary HCC samples are now ongoing. Considering that HCC has high rates of recurrence and mortality, novel therapeutic approaches are urgently required. Although the clinical relevance of CSCs remains elusive, deep understanding of the cellular organization of HCC may allow us to develop therapies targeting specific cell types such as CSCs. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据